Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
endometrial hyperplasia/rasvumus
Link salvestatakse lõikelauale
Leht 1 alates 175 tulemused
Aromatase inhibitor anastrozole for treating endometrial hyperplasia in obese postmenopausal women.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This is a preliminary study investigating the efficacy of aromatase inhibitor anastrozole in treating endometrial hyperplasia in obese postmenopausal women. We administered anastrozole for 12 months to 11 obese postmenopausal women with high operative risk, in order to treat endometrial hyperplasia
[Incidence of the risk factors age and obesity in patients with endometrial hyperplasia].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This investigation pursued the question of how many patients with precancerous endometrial hyperplasia were not recommended for screening programs solely because of the lack of risk factors. The median age of precancerous hyperplasia patients in Erlangen is 54, 8 years before the median age for
Endometrial polyps associated with endometrial hyperplasia in an obese bonnet monkey (Macaca radiata): a case report.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
A 10-year-old, female bonnet monkey (Macaca radiata) showed abnormal menstrual cycle length with heavy menstrual bleeding for 6-8 days.
METHODS
Uterine ultrasound and histological examinations of endometrium by endometrial biopsy.
RESULTS
An ultrasound examination of the uterine cavity
Serum adiponectin in relation to endometrial cancer and endometrial hyperplasia with atypia in obese women.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
The aim of this work was to compare concentrations of adiponectin in the serum of obese women with endometrial cancer, endometrial hyperplasia with atypia, and normal endometrium.
METHODS
We enrolled 105 obese women treated at the Department of Gynecological Surgery and Oncology of Adults
The use of novel technology-based weight loss interventions for obese women with endometrial hyperplasia and cancer.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
Obesity significantly increases the risk of the development of both endometrial hyperplasia and cancer. Our objective was to assess the feasibility of two technology-based weight loss interventions in this patient population.
METHODS
Women with obesity (BMI≥30kg/m(2)) and endometrial
Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The aim of this retrospective study was to evaluate the efficacy of levonorgestrel intrauterine system-releasing (LNG-IUS) insertion in preventing atypical endometrial hyperplasia (AH) and endometrial cancer (EC) in symptomatic postmenopausal overweight/obese women. A total of 34 overweight/obese
Adipose-derived VEGF-mTOR Signaling Promotes Endometrial Hyperplasia and Cancer: Implications for Obese Women.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Obesity is responsible for increased morbidity and mortality in endometrial cancer. Despite the positive correlation of body mass index (BMI) or obesity in endometrial carcinogenesis, the contribution of adipose tissue to the pathogenesis of endometrial hyperplasia and cancer is unclear. This study
Obesity and endometrial hyperplasia and cancer in premenopausal women: A systematic review.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
To systematically review the literature on the association between obesity and endometrial hyperplasia or cancer in premenopausal women.
We searched the bibliographic databases MEDLINE, EMBASE, PubMed, and CINAHL (inception to May 5, 2015), and checked reference lists of included studies and
Conservative management of endometrial hyperplasia or carcinoma with the levonorgestrel intrauterine system may be less effective in morbidly obese patients.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
•Endometrial hyperplasia/carcinoma regression rates with LNG-IUS were examined by BMI.•Morbidly obese patients with EH/EHA/EC are more likely to progress.•Despite addition of oral progesterone to LNG-IUS, morbid obesity increases the odds of progression.
Endometrial hyperplasia, endometrial cancer, and obesity: convergent mechanisms regulating energy homeostasis and cellular proliferation.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Management of abnormal uterine hemorrhage with atypical endometrial hyperplasia by transcervical resection of endometrium.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The aim of the study was to assess the feasibility and effect of treating atypical endometrial hyperplasia (AEH) with transcervical resection of endometrium (TCRE). Five cases of AEH incapable of hysterectomy for various reasons were treated with TCRE. All patients were followed up for 3-4 years
Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptorelin: a prospective study.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Endometrial hyperplasia is thought to be caused by the prolonged, unopposed oestrogenic stimulation of the endometrium. The regression of hyperplastic back to normal endometrium is the main purpose of any conservative treatment in order to prevent development of adenocarcinoma. The aim of this study
Descriptive epidemiology of endometrial hyperplasia in patients with abnormal uterine bleeding.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
To evaluate the prevalence and epidemiologic characteristics of endometrial hyperplasias in women with abnormal uterine bleeding.
METHODS
We performed a retrospective analysis on data gained from 294 patients with histologically documented endometrial hyperplasia (with or without atypia),
Atypical Endometrial Hyperplasia Arising in a Cesarean Section Scar: A Mechanism of Malignant Transformation.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The incidence of scar endometriosis in Cesarean sections varies between 0.03 and 0.4%. However, the recently increased rate of Cesarean sections worldwide may be causing an increase in occurrence of scar endometriosis. This report presents anatomopathological evidence of an early-stage malignant
Risk factors for endometrial hyperplasia concomitant endometrial polyps in pre- and post-menopausal women.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
To evaluate the risk factors for endometrial hyperplasia concomitant endometrial polyps in pre- and post-menopausal women.
METHODS
A total of 203 patients undergoing endometrial sampling before hysterectomy were evaluated in this retrospective study. Data recorded were age, gravidity,
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
